The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been down 1.3% at 8,235 points in afternoon trade.

Profit takers have swooped in after the bourse came within a whisker of yet another record high yesterday.

Investors have pared RBA rate cut expectations after three year bond yields spiked and traders delayed their timing of the first rate cut to May.

It’s a sea of red as all sectors are retreating. Real Estate is the worst performer, down 2.1%, followed by Health Care, down 1.9% and Discretionary, down 1.7%.

Company News

Wisetech (ASX:WTC) has been up 0.6% on news its billionaire founder Richard White has settled his legal battle with former lover Linda Rogan. Yesterday saw almost 15% and $6 billion in market cap wiped from the company’s valuation.

Wisetech has been $105.27

Magnetite Mines (ASX:MGT) has been up around 3% after joining a consortium aimed at accelerating South Australia’s green iron industry.

Magnetite Mines has been 17.5 cents.

Neometals (ASX:NMT) has confirmed Primobius, its 50/50 Joint Venture with Europe’s SMS Group, is now crucial to Mercedes Benz’s battery recycling strategy.

Neometals closed at 9.4 cents.

More From The Market Online
The words "ASX Market Open" appear alongside a Bull ( RISE ) with a market chart graphic floating above it. The whole image is faded yellow and orange.

Market Open: First-quarter GDP data the big Oz watch today; AI helps US higher

At The Bell — Aussie shares will open higher this morning, +0.5% in ASX 200 futures as the bourse braces for GDP dat…

Sunstone Metals continues to shine with gold-copper hits at Porotillo

Sunstone Metals has hit further long intervals of gold and copper mineralisation outside the existing resource…

Minrex Resources spinning the bit at Barje deposit in southern Serbia

Minrex Resources is targeting a resource upgrade with drilling within the North-Eastern contours of the Barje…
The Market Online Video

AFT Pharma delivers record FY26 as global growth accelerates

AFT Pharma founder and chief executive Hartley Atkinson talks strong sales growth, ongoing R&D initiatives, and…